Potential role of leukotrienes in other disease states
dc.contributor.author | Peters-Golden, Marc L. | en_US |
dc.date.accessioned | 2010-06-01T21:19:26Z | |
dc.date.available | 2010-06-01T21:19:26Z | |
dc.date.issued | 2001-07 | en_US |
dc.identifier.citation | Peters-Golden, M (2001). "Potential role of leukotrienes in other disease states." Clinical & Experimental Allergy Reviews 1(2): 178-182. <http://hdl.handle.net/2027.42/74393> | en_US |
dc.identifier.issn | 1472-9725 | en_US |
dc.identifier.issn | 1472-9733 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/74393 | |
dc.format.extent | 88136 bytes | |
dc.format.extent | 3109 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Science Ltd | en_US |
dc.rights | Blackwell Science Ltd | en_US |
dc.title | Potential role of leukotrienes in other disease states | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Microbiology and Immunology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Division of Pulmonary and Critical Care Medicine, University of Michigan Health System, Ann Arbor, Michigan, USA | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/74393/1/j.1472-9725.2001.00036.x.pdf | |
dc.identifier.doi | 10.1046/j.1472-9725.2001.00036.x | en_US |
dc.identifier.source | Clinical & Experimental Allergy Reviews | en_US |
dc.identifier.citedreference | Antonelli M, Bufi M, De Blasi R et al. Detection of leukotrienes B 4, C 4 and of their isomers in arterial, mixed venous blood and bronchoalveolar lavage fluid from ARDS patients. Intensive Care Med 1989; 1: 296 – 301. | en_US |
dc.identifier.citedreference | Stephenson A, Lonigro A, Hyers T, Webster R, Fowler A. Increased concentrations of leukotrienes in bronchoalveolar lavage fluid of patients with ARDS or at risk of ARDS. Am Rev Respir Dis 1988; 1: 714 – 9. | en_US |
dc.identifier.citedreference | Bernard G, Korley V, Swindell B, Ford-Hutchinson A, Tagari P. Persistent generation of peptido leukotrienes in patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1991; 1: 263 – 7. | en_US |
dc.identifier.citedreference | Taniguchi H, Taki F, Takagi K, Satake T, Sugiyama S, Ozawa T. The role of leukotriene B 4 in the genesis of oxygen toxicity in the lung. Am Rev Respir Dis 1986; 1: 805 – 8. | en_US |
dc.identifier.citedreference | VanderMeer T, Menconi M, O'Sullivan B et al. Acute lung injury in endotoxemic pigs: role of leukotriene B 4. J Appl Physiol 1995; 1: 1121 – 31. | en_US |
dc.identifier.citedreference | Cohn S, Kruithoff K, Rothschild H, Wang H, Antonsson J, Fink M. Beneficial effects of LY203647, a novel leukotriene C 4 /D 4 antagonist, on pulmonary function and mesenteric perfusion in a porcine model of endotoxic shock and ARDS. Circ Shock 1991; 1: 7 – 16. | en_US |
dc.identifier.citedreference | Baud L, Perez J, Denis M, Ardaillou R. Modulation of fibroblast proliferation by sulfidopeptide leukotrienes: effect of indomethacin. J Immunol 1987; 1: 1190 – 5. | en_US |
dc.identifier.citedreference | Phan S, McGarry B, Loeffler K, Kunkel S. Binding of leukotriene C 4 to rat lung fibroblasts and stimulation of collagen synthesis in vitro. Biochemistry 1988; 1: 2846 – 53. | en_US |
dc.identifier.citedreference | Wardlaw A, Hay H, Cromwell O, Collins J, Kay A. Leukotrienes. LTC 4 and LTB 4, in bronchoalveolar lavage in bronchial asthma and other respiratory diseases. J Allergy Clin Immunol 1989; 1: 19 – 26. | en_US |
dc.identifier.citedreference | Wilborn J, Bailie M, Coffey M, Burdick M, Strieter R, Peters-Golden M. Constitutive activation of 5-lipoxygenase in the lungs of patients with idiopathic pulmonary fibrosis. J Clin Invest 1996; 1: 1827 – 36. | en_US |
dc.identifier.citedreference | Garcia J, Griffith D, Cohen A, Callahan K. Alveolar macrophages from patients with asbestos exposure release increased levels of leukotriene B 4. Am Rev Respir Dis 1989; 1: 1494 – 501. | en_US |
dc.identifier.citedreference | Phan S & Kunkel S. Inhibition of bleomycin-induced pulmonary fibrosis by nordihydroguiaretic acid. The role of alveolar macrophage activation and mediator production. Am J Pathol 1986; 1: 343 – 52. | en_US |
dc.identifier.citedreference | Ziboh V, Yun M, Hyde D, Giri S. Gamma-linolenic acid-containing diet attenuates bleomycin-induced lung fibrosis in hamsters. Lipids 1997; 1: 759 – 67. | en_US |
dc.identifier.citedreference | Avis I, Jett M, Boyle T et al. Growth control of lung cancer by interruption of 5-lipoxygenase-mediated growth factor signaling. J Clin Invest 1996; 1: 806 – 13. | en_US |
dc.identifier.citedreference | Rioux N & Castonguay A. Inhibitors of lipoxygenase: a new class of cancer chemopreventive agents. Carcinogenesis 1998; 1: 1393 – 400. | en_US |
dc.identifier.citedreference | Hubbard R, Venn A, Lewis S, Britton J. Lung cancer and cryptogenic fibrosing alveolitis; a population-based cohort study. Am J Respir Crit Care Med 2000; 1: 5 – 8. | en_US |
dc.identifier.citedreference | Huovinen E, Kaprio J, Vesterinen E, Koskenvuo M. Mortality of adults with asthma: a prospective cohort study. Thorax 1997; 1: 49 – 54. | en_US |
dc.identifier.citedreference | Bailie M, Standiford T, Laichalk L, Coffey M, Strieter R, Peters-Golden M. Leukotriene-deficient mice manifest enhanced lethality from Klebsiella pneumonia in association with decreased alveolar macrophage phagocytic and bactericidal activities. J Immunol 1996; 1: 5221 – 4. | en_US |
dc.identifier.citedreference | Hopkins H, Stull T, Von Essen S, Robbins R, Rennard S. Neutrophil chemotactic factors in bacterial pneumonia. Chest 1989; 1: 1021 – 7. | en_US |
dc.identifier.citedreference | Peters-Golden M & Coffey M. Role of leukotrienes in antimicrobial defense of the lung. J Lab Clin Med 1998; 1: 251 – 7. | en_US |
dc.identifier.citedreference | Mancuso P, Standiford T, Marshall T, Peters-Golden M. 5-Lipoxygenase reaction products modulate rat alveolar macrophage phagocytosis of Klebsiella pneumoniae. Infect Immun 1998; 1: 5140 – 6. | en_US |
dc.identifier.citedreference | Coffey M, Phare S, George S, Peters-Golden M, Kazanjian P. Granulocyte colony-stimulating factor administration to HIV-infected subjects augments reduced leukotriene synthesis and anticryptococcal activity in neutrophils. J Clin Invest 1998; 1: 663 – 70. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.